1,827 Shares in Elevance Health, Inc. (NYSE:ELV) Purchased by Chapman Financial Group LLC

Chapman Financial Group LLC purchased a new stake in Elevance Health, Inc. (NYSE:ELV - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 1,827 shares of the company's stock, valued at approximately $674,000.

Several other hedge funds and other institutional investors also recently modified their holdings of ELV. Accredited Wealth Management LLC acquired a new position in Elevance Health during the fourth quarter worth about $25,000. Flagship Wealth Advisors LLC acquired a new position in Elevance Health during the 4th quarter worth approximately $26,000. OFI Invest Asset Management bought a new position in Elevance Health in the 4th quarter valued at approximately $29,000. WealthTrak Capital Management LLC acquired a new stake in Elevance Health in the fourth quarter valued at approximately $29,000. Finally, Lee Danner & Bass Inc. bought a new stake in shares of Elevance Health during the fourth quarter worth $30,000. Institutional investors own 89.24% of the company's stock.

Insider Transactions at Elevance Health

In other news, CFO Mark Kaye sold 4,588 shares of the business's stock in a transaction that occurred on Thursday, April 24th. The shares were sold at an average price of $424.82, for a total value of $1,949,074.16. Following the sale, the chief financial officer now owns 18,977 shares of the company's stock, valued at $8,061,809.14. The trade was a 19.47 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Charles Morgan Kendrick, Jr. sold 3,504 shares of the firm's stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $396.30, for a total value of $1,388,635.20. Following the completion of the transaction, the executive vice president now directly owns 10,116 shares of the company's stock, valued at $4,008,970.80. The trade was a 25.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 8,535 shares of company stock worth $3,521,612 in the last 90 days. Insiders own 0.29% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on ELV. Cantor Fitzgerald restated an "overweight" rating and set a $485.00 price objective on shares of Elevance Health in a research report on Wednesday, April 23rd. Mizuho boosted their price target on Elevance Health from $455.00 to $505.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Barclays raised their price objective on shares of Elevance Health from $512.00 to $522.00 and gave the company an "overweight" rating in a report on Wednesday, April 23rd. Baird R W lowered shares of Elevance Health from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Finally, Truist Financial raised their price target on shares of Elevance Health from $480.00 to $510.00 and gave the company a "buy" rating in a research note on Friday, April 11th. Four equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat.com, Elevance Health has an average rating of "Moderate Buy" and an average price target of $510.38.

Elevance Health Trading Down 1.9 %

Shares of ELV stock traded down $7.86 during trading hours on Friday, hitting $404.52. 948,113 shares of the company were exchanged, compared to its average volume of 1,662,630. The company has a 50 day simple moving average of $424.00 and a two-hundred day simple moving average of $404.69. The firm has a market cap of $91.40 billion, a P/E ratio of 15.80, a P/E/G ratio of 1.18 and a beta of 0.66. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.50 and a current ratio of 1.45. Elevance Health, Inc. has a fifty-two week low of $362.21 and a fifty-two week high of $567.26.

Elevance Health (NYSE:ELV - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The company reported $11.97 earnings per share for the quarter, beating the consensus estimate of $10.60 by $1.37. The firm had revenue of $48.77 billion for the quarter, compared to analyst estimates of $46.26 billion. Elevance Health had a net margin of 3.38% and a return on equity of 18.28%. Equities analysts anticipate that Elevance Health, Inc. will post 33.96 EPS for the current year.

Elevance Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Tuesday, June 10th will be given a $1.71 dividend. This represents a $6.84 dividend on an annualized basis and a yield of 1.69%. The ex-dividend date is Tuesday, June 10th. Elevance Health's payout ratio is 26.69%.

Elevance Health Company Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.